Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2871-2879
Published online before print June 12, 2006, doi: 10.1161/CIRCULATIONAHA.105.594531
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/25/2871    most recent
CIRCULATIONAHA.105.594531v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, P. A.
Right arrow Articles by Glikson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, P. A.
Right arrow Articles by Glikson, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Arrhythmia
*Pacemakers and Implantable Defibrillators
Related Collections
Right arrow Other Treatment
Right arrowRelated Article

(Circulation. 2006;113:2871-2879.)
© 2006 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis

The Detect Supraventricular Tachycardia Study

Paul A. Friedman, MD; Robyn L. McClelland, PhD; William R. Bamlet, MS; Helbert Acosta, MD; David Kessler, MD; Thomas M. Munger, MD; Neal G. Kavesh, MD; Mark Wood, MD; Emile Daoud, MD; Ali Massumi, MD; Claudio Schuger, MD; Stephen Shorofsky, MD; Bruce Wilkoff, MD; Michael Glikson, MD

From the Division of Cardiovascular Diseases (P.A.F., T.M.M.) and the Division of Biostatistics (R.L.M., W.R.B.), Mayo Clinic, Rochester, Minn; Electrophysiology, Trinity Medical Center, Rock Island, Ill (H.A.); Electrophysiology and Cardiac Pacing, Austin Heart, Austin, Tex (D.K.); Cardiology/Electrophysiology, Watson Clinic, Lakeland, Fla (N.G.K.); Internal Medicine/Cardiology, Virginia Commonwealth University, Richmond (M.W.); Cardiovascular Disease, MidWest Research Foundation, Riverside Methodist Hospital, Columbus, Ohio (E.D.); Center for Cardiac Arrhythmias and Electrophysiology, Texas Heart Institute, Houston (A.M.); Cardiology, Henry Ford Hospital, Detroit, Mich (C.S.); Maryland Heart Center, University of Maryland Medical Center, Baltimore (S.S.); Cardiovascular Disease, The Cleveland Clinic Foundation, Cleveland, Ohio (B.W.); and Electrophysiology and Pacing, Heart Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (M.G.).

Correspondence to Paul A. Friedman, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Received October 19, 2005; revision received February 17, 2006; accepted April 7, 2006.

Background— Delivery of inappropriate shocks caused by misdetection of supraventricular tachycardia (SVT) remains a substantial complication of implanted cardioverter/defibrillator (ICD) therapy. Whether use of optimally programmed dual-chamber ICDs lowers this risk compared with that in single-chamber ICDs is not clear.

Methods and Results— Subjects with a clinical indication for ICD (n=400) at 27 participating centers received dual-chamber ICDs and were randomly assigned to strictly defined optimal single- or dual-chamber detection in a single-blind manner. Programming minimized ventricular pacing. The primary end point was the proportion of SVT episodes inappropriately detected from the time of programming until crossover or end of study. On a per-episode basis, 42% of the episodes in the single-chamber arm and 69% of the episodes in the dual-chamber arm were due to SVT. Mortality (3.5% in both groups) and early study withdrawal (14% single-chamber, 11% dual-chamber) were similar in both groups. The rate of inappropriate detection of SVT was 39.5% in the single-chamber detection arm compared with 30.9% in the dual-chamber arm. The odds of inappropriate detection were decreased by almost half with the use of the dual-chamber detection enhancements (odds ratio, 0.53; 95% confidence interval, 0.30 to 0.94; P=0.03).

Conclusions— Dual-chamber ICDs, programmed to optimize detection enhancements and to minimize ventricular pacing, significantly decrease inappropriate detection.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2006 113: 2861. [Full Text]



This article has been cited by other articles:


Home page
EuropaceHome page
G. Boriani, E. Occhetta, S. Cesario, S. Grossi, M. Marconi, G. Speca, P. Silvestri, M. Biffi, M. Bortnik, C. Martignani, et al.
Contribution of morphology discrimination algorithm for improving rhythm discrimination in slow and fast ventricular tachycardia zones in dual-chamber implantable cardioverter-defibrillators
Europace, June 9, 2008; (2008) eun146v1.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
HeartHome page
L. van Erven and M. J Schalij
Troubleshooting implantable cardioverter-defibrillator related problems
Heart, May 1, 2008; 94(5): 649 - 660.
[Full Text] [PDF]


Home page
EuropaceHome page
J. Almendral, F. Arribas, C. Wolpert, R. Ricci, P. Adragao, E. Cobo, X. Navarro, A. Quesada, and the DATAS Steering Committee and Writing Committee
Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial
Europace, May 1, 2008; 10(5): 528 - 535.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. P. Daubert, W. Zareba, D. S. Cannom, S. McNitt, S. Z. Rosero, P. Wang, C. Schuger, J. S. Steinberg, S. L. Higgins, D. J. Wilber, et al.
Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II: Frequency, Mechanisms, Predictors, and Survival Impact
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1357 - 1365.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. Worck, J. Haarbo, and P. E. B. Thomsen
Electrophysiological study and 'slow' ventricular tachycardia predict appropriate therapy: results from a single-centre implantable cardiac defibrillator follow-up
Europace, November 1, 2007; 9(11): 1048 - 1053.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. A. Ezekowitz, B. H. Rowe, D. M. Dryden, N. Hooton, B. Vandermeer, C. Spooner, and F. A. McAlister
Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction
Ann Intern Med, August 21, 2007; 147(4): 251 - 262.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Passman and A. Kadish
Sudden Death Prevention With Implantable Devices
Circulation, July 31, 2007; 116(5): 561 - 571.
[Full Text] [PDF]


Home page
CirculationHome page
M. H. Schoenfeld
Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist
Circulation, February 6, 2007; 115(5): 638 - 653.
[Full Text] [PDF]


Home page
Clin TrialsHome page
R. L McClelland, W. R Bamlet, M. Glikson, and P. A Friedman
Design and analysis issues in cardiac arrhythmia trials: insights from the Detect Supraventricular Tachycardia Trial
Clinical Trials, February 1, 2007; 4(1): 74 - 80.
[Abstract] [PDF]


Home page
JAMAHome page
A. K. Gehi, D. Mehta, and J. A. Gomes
Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock
JAMA, December 20, 2006; 296(23): 2839 - 2847.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. O. Sweeney
Overcoming the Defects of a Virtue: Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study
Circulation, June 27, 2006; 113(25): 2862 - 2864.
[Full Text] [PDF]